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Introduction 
Radiotherapy of pituitary adenomas is often applied as postoperative 
therapy of tumors that cannot be removed completely. Fluence 
modulating techniques like IMRT or VMAT support the use of the 
flatness filter free (FFF) mode in modern linear accelerators. In this 
mode a considerably higher dose rate is achieved by omitting the 
flatness filter. This planning study compares different plans for 
patients with pituitary adenoma.  The plans were optimized using both 
modes: flattened beam (FB) and FFF. The aim of this study is to 
evaluate the plan quality.  
 
Material and methods 
Data sets of 11 patients with pituitary adenoma were used for this 
retrospective planning study. The objectives for the PTV were set to a 
minimum dose of 49.4Gy and a maximum dose of 51.4Gy in 28 
fractions, aiming for a fraction dose of 1.8Gy. Further objectives were 
set for the following regions of interest (ROI): brain, brainstem, 
chiasm, and both lenses, bulbs, lacrimal glands, and parotids (table 
1). The planning was performed with the treatment planning system 
(TPS) Oncentra External Beam v4.5 (Elekta AB, Sweden) using the 
collapsed cone algorithm. In both modes (FB and FFF) IMRT plans 
with nine equispaced coplanar fields were generated (IMRT9); in a 
second variant a tenth non-coplanar field was added (IMRT10). 
Similarly two VMAT plans were optimized: one single arc rotation 
(182°-178°)(VMAT1), and the second with an added half rotation in 
the sagittal patient plane (0°-180°)(VMAT2). The applied linac 
Synergy Agility (Elekta AB, Sweden) offers a dose rate of 550MU/min 
(FB) and 1700MU/min (FFF). The leaves have a width of 5mm 
projected to the isocenter. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1. Treatment Planning Objectives 
 
The following parameters were evaluated:  the average dose DAv to the 
PTV, homogeneity index HI, and the conformity index CI. For all plans 
the observance of the objectives for the organs at risk given in table 1 
was investigated. The data were analyzed with SPSS® (IBM, USA) to 
generate diagrams and visualize statistical parameters. 
 
 
 
 
 
 
 
Results 
For both modes FB and FFF the dose volume statistics are very close.  
With some minor exceptions the objectives for the ROIs are met. Only 
the maximum dose to the chiasm is slightly exceeded in most cases, 
as it is part of the PTV. Regarding the PTV (HI and CI) pronounced 
differences are found in the comparison of IMRT and VMAT (diagram 
1 and 2) showing  a benefit for VMAT. The distinction between 
coplanar and non-coplanar techniques is less important.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Diagram 1. Boxplot of the conformity index CI of the different plan variants, showing 
mean value, inner quartile (box) and outer quartile (bar), and a few outliers (circles) and 
extreme value (asterisk). FB yellow, FFF blue. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Diagram 1. Boxplot of the homogeneity index HI of the different plan variants, showing 
mean value, inner quartile (box) and outer quartile (bar). FB yellow, FFF blue. 
 
Discussion  
The difference in the plan quality of FB and FFF plans is of no clinical 
importance. A decision for the preferred treatment technique will 
therefore be taken based on measurements of the delivery time and 
peripheral dose which will follow. As the plan quality of VMAT is 
superior to IMRT, the decision will be made between VMAT FB and 
VMAT FFF. All non-coplanar techniques will require more linac time 
due to couch rotations without showing advantages in plan quality. 
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Organ at Risk max Dose in Gy max Volume in % 
Brain 20 20 
  30 10 
  40 5 
Brainstem 51.4 0 
Chiasm 50 0 
Lens 15 0 
Bulb 35 50 
Lacrimal gland 20 50 
Parotid 30 50 
